EL PASO, Texas (KVIA) — Dr. Nils Nickel was named the principal investigator for a national study that is taking place in El Paso and will help expand lung care across the country.
Dr. Nickel works with the Texas Tech University Health Sciences Center as a pulmolonegist and is working to help innovate a new medicine to help bust blood clots.
The study will help create a new medicine called TS23. It will expand local access to clinical trials. The medicine is primarily used to help with pulmonary embolism, which happens when blood clots travel up to your lungs…